BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, has launched a new interactive website to provide patients and their families with information about short bowel syndrome (SBS). Short bowel syndrome is a rare and debilitating condition in which the body is unable to absorb enough nutrients and/or fluids through the gastrointestinal tract. There are an estimated 15,000 patients with SBS in the United States who rely on chronic intravenous or parenteral nutrition to survive.
